Ischemia Reperfusion Injury Industry Research Report 2025

Summary

Reperfusion injury or reperfusion insult, sometimes called ischemia-reperfusion injury (IRI) or reoxygenation injury, is the tissue damage caused when blood supply returns to tissue (re- + perfusion) after a period of ischemia or lack of oxygen (anoxia or hypoxia). The absence of oxygen and nutrients from blood during the ischemic period creates a condition in which the restoration of circulation results in inflammation and oxidative damage through the induction of oxidative stress rather than (or along with) restoration of normal function.

According to APO Research, The global Ischemia Reperfusion Injury market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Ischemia Reperfusion Injury is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Ischemia Reperfusion Injury is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Ischemia Reperfusion Injury is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Ischemia Reperfusion Injury include Angion Biomedica, Catalyst Biosciences, Ischemix Inc, Opsona Therapeutics, Pharming, TheraSource, Bolder Biotechnology, Corline Biomedical and Mifcortx, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Ischemia Reperfusion Injury, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ischemia Reperfusion Injury.
The Ischemia Reperfusion Injury market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Ischemia Reperfusion Injury market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Ischemia Reperfusion Injury Segment by Company

Angion Biomedica
Catalyst Biosciences
Ischemix Inc
Opsona Therapeutics
Pharming
TheraSource
Bolder Biotechnology
Corline Biomedical
Mifcortx
Balmes Transplantation
NovelMed Therapeutics
Hope Pharmaceuticals
Omeros Corp
Prothix
SBI Pharmaceuticals
Ischemia Reperfusion Injury Segment by Type

Phase 1
Phase 2
Preclinical
Ischemia Reperfusion Injury Segment by Application

Heart Injury
Kidney Injury
Intestine Injury
Other Injury
Ischemia Reperfusion Injury Segment by Application

Heart Injury
Kidney Injury
Intestine Injury
Other Injury
Ischemia Reperfusion Injury Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ischemia Reperfusion Injury market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ischemia Reperfusion Injury and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ischemia Reperfusion Injury.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Ischemia Reperfusion Injury companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Ischemia Reperfusion Injury by Type
2.2.1 Market Value Comparison by Type (2020 VS 2024 VS 2031)
2.2.2 Phase 1
2.2.3 Phase 2
2.2.4 Preclinical
2.3 Ischemia Reperfusion Injury by Application
2.3.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.3.2 Heart Injury
2.3.3 Kidney Injury
2.3.4 Intestine Injury
2.3.5 Other Injury
2.4 Assumptions and Limitations
3 Ischemia Reperfusion Injury Breakdown Data by Type
3.1 Global Ischemia Reperfusion Injury Historic Market Size by Type (2020-2025)
3.2 Global Ischemia Reperfusion Injury Forecasted Market Size by Type (2026-2031)
4 Ischemia Reperfusion Injury Breakdown Data by Application
4.1 Global Ischemia Reperfusion Injury Historic Market Size by Application (2020-2025)
4.2 Global Ischemia Reperfusion Injury Forecasted Market Size by Application (2026-2031)
5 Global Growth Trends
5.1 Global Ischemia Reperfusion Injury Market Perspective (2020-2031)
5.2 Global Ischemia Reperfusion Injury Growth Trends by Region
5.2.1 Global Ischemia Reperfusion Injury Market Size by Region: 2020 VS 2024 VS 2031
5.2.2 Ischemia Reperfusion Injury Historic Market Size by Region (2020-2025)
5.2.3 Ischemia Reperfusion Injury Forecasted Market Size by Region (2026-2031)
5.3 Ischemia Reperfusion Injury Market Dynamics
5.3.1 Ischemia Reperfusion Injury Industry Trends
5.3.2 Ischemia Reperfusion Injury Market Drivers
5.3.3 Ischemia Reperfusion Injury Market Challenges
5.3.4 Ischemia Reperfusion Injury Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Ischemia Reperfusion Injury Players by Revenue
6.1.1 Global Top Ischemia Reperfusion Injury Players by Revenue (2020-2025)
6.1.2 Global Ischemia Reperfusion Injury Revenue Market Share by Players (2020-2025)
6.2 Global Ischemia Reperfusion Injury Industry Players Ranking, 2023 VS 2024 VS 2025
6.3 Global Key Players of Ischemia Reperfusion Injury Head Office and Area Served
6.4 Global Ischemia Reperfusion Injury Players, Product Type & Application
6.5 Global Ischemia Reperfusion Injury Manufacturers Established Date
6.6 Global Ischemia Reperfusion Injury Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Ischemia Reperfusion Injury Market Size (2020-2031)
7.2 North America Ischemia Reperfusion Injury Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 North America Ischemia Reperfusion Injury Market Size by Country (2020-2025)
7.4 North America Ischemia Reperfusion Injury Market Size by Country (2026-2031)
7.5 United States
7.5 United States
7.6 Canada
7.7 Mexico
8 Europe
8.1 Europe Ischemia Reperfusion Injury Market Size (2020-2031)
8.2 Europe Ischemia Reperfusion Injury Market Growth Rate by Country: 2020 VS 2024 VS 2031
8.3 Europe Ischemia Reperfusion Injury Market Size by Country (2020-2025)
8.4 Europe Ischemia Reperfusion Injury Market Size by Country (2026-2031)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Spain
8.10 Russia
8.11 Netherlands
8.12 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Ischemia Reperfusion Injury Market Size (2020-2031)
9.2 Asia-Pacific Ischemia Reperfusion Injury Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Asia-Pacific Ischemia Reperfusion Injury Market Size by Country (2020-2025)
9.4 Asia-Pacific Ischemia Reperfusion Injury Market Size by Country (2026-2031)
9.5 China
9.6 Japan
9.7 South Korea
9.8 India
9.9 Australia
9.10 China Taiwan
9.11 Southeast Asia
10 South America
10.1 South America Ischemia Reperfusion Injury Market Size (2020-2031)
10.2 South America Ischemia Reperfusion Injury Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 South America Ischemia Reperfusion Injury Market Size by Country (2020-2025)
10.4 South America Ischemia Reperfusion Injury Market Size by Country (2026-2031)
10.5 Brazil
10.6 Argentina
10.7 Chile
10.8 Colombia
10.9 Peru
11 Middle East & Africa
11.1 Middle East & Africa Ischemia Reperfusion Injury Market Size (2020-2031)
11.2 Middle East & Africa Ischemia Reperfusion Injury Market Growth Rate by Country: 2020 VS 2024 VS 2031
11.3 Middle East & Africa Ischemia Reperfusion Injury Market Size by Country (2020-2025)
11.4 Middle East & Africa Ischemia Reperfusion Injury Market Size by Country (2026-2031)
11.5 Saudi Arabia
11.6 Israel
11.7 United Arab Emirates
11.8 Turkey
11.9 Iran
11.10 Egypt
12 Players Profiled
12.1 Angion Biomedica
12.1.1 Angion Biomedica Company Information
12.1.2 Angion Biomedica Business Overview
12.1.3 Angion Biomedica Revenue in Ischemia Reperfusion Injury Business (2020-2025)
12.1.4 Angion Biomedica Ischemia Reperfusion Injury Product Portfolio
12.1.5 Angion Biomedica Recent Developments
12.2 Catalyst Biosciences
12.2.1 Catalyst Biosciences Company Information
12.2.2 Catalyst Biosciences Business Overview
12.2.3 Catalyst Biosciences Revenue in Ischemia Reperfusion Injury Business (2020-2025)
12.2.4 Catalyst Biosciences Ischemia Reperfusion Injury Product Portfolio
12.2.5 Catalyst Biosciences Recent Developments
12.3 Ischemix Inc
12.3.1 Ischemix Inc Company Information
12.3.2 Ischemix Inc Business Overview
12.3.3 Ischemix Inc Revenue in Ischemia Reperfusion Injury Business (2020-2025)
12.3.4 Ischemix Inc Ischemia Reperfusion Injury Product Portfolio
12.3.5 Ischemix Inc Recent Developments
12.4 Opsona Therapeutics
12.4.1 Opsona Therapeutics Company Information
12.4.2 Opsona Therapeutics Business Overview
12.4.3 Opsona Therapeutics Revenue in Ischemia Reperfusion Injury Business (2020-2025)
12.4.4 Opsona Therapeutics Ischemia Reperfusion Injury Product Portfolio
12.4.5 Opsona Therapeutics Recent Developments
12.5 Pharming
12.5.1 Pharming Company Information
12.5.2 Pharming Business Overview
12.5.3 Pharming Revenue in Ischemia Reperfusion Injury Business (2020-2025)
12.5.4 Pharming Ischemia Reperfusion Injury Product Portfolio
12.5.5 Pharming Recent Developments
12.6 TheraSource
12.6.1 TheraSource Company Information
12.6.2 TheraSource Business Overview
12.6.3 TheraSource Revenue in Ischemia Reperfusion Injury Business (2020-2025)
12.6.4 TheraSource Ischemia Reperfusion Injury Product Portfolio
12.6.5 TheraSource Recent Developments
12.7 Bolder Biotechnology
12.7.1 Bolder Biotechnology Company Information
12.7.2 Bolder Biotechnology Business Overview
12.7.3 Bolder Biotechnology Revenue in Ischemia Reperfusion Injury Business (2020-2025)
12.7.4 Bolder Biotechnology Ischemia Reperfusion Injury Product Portfolio
12.7.5 Bolder Biotechnology Recent Developments
12.8 Corline Biomedical
12.8.1 Corline Biomedical Company Information
12.8.2 Corline Biomedical Business Overview
12.8.3 Corline Biomedical Revenue in Ischemia Reperfusion Injury Business (2020-2025)
12.8.4 Corline Biomedical Ischemia Reperfusion Injury Product Portfolio
12.8.5 Corline Biomedical Recent Developments
12.9 Mifcortx
12.9.1 Mifcortx Company Information
12.9.2 Mifcortx Business Overview
12.9.3 Mifcortx Revenue in Ischemia Reperfusion Injury Business (2020-2025)
12.9.4 Mifcortx Ischemia Reperfusion Injury Product Portfolio
12.9.5 Mifcortx Recent Developments
12.10 Balmes Transplantation
12.10.1 Balmes Transplantation Company Information
12.10.2 Balmes Transplantation Business Overview
12.10.3 Balmes Transplantation Revenue in Ischemia Reperfusion Injury Business (2020-2025)
12.10.4 Balmes Transplantation Ischemia Reperfusion Injury Product Portfolio
12.10.5 Balmes Transplantation Recent Developments
12.11 NovelMed Therapeutics
12.11.1 NovelMed Therapeutics Company Information
12.11.2 NovelMed Therapeutics Business Overview
12.11.3 NovelMed Therapeutics Revenue in Ischemia Reperfusion Injury Business (2020-2025)
12.11.4 NovelMed Therapeutics Ischemia Reperfusion Injury Product Portfolio
12.11.5 NovelMed Therapeutics Recent Developments
12.12 Hope Pharmaceuticals
12.12.1 Hope Pharmaceuticals Company Information
12.12.2 Hope Pharmaceuticals Business Overview
12.12.3 Hope Pharmaceuticals Revenue in Ischemia Reperfusion Injury Business (2020-2025)
12.12.4 Hope Pharmaceuticals Ischemia Reperfusion Injury Product Portfolio
12.12.5 Hope Pharmaceuticals Recent Developments
12.13 Omeros Corp
12.13.1 Omeros Corp Company Information
12.13.2 Omeros Corp Business Overview
12.13.3 Omeros Corp Revenue in Ischemia Reperfusion Injury Business (2020-2025)
12.13.4 Omeros Corp Ischemia Reperfusion Injury Product Portfolio
12.13.5 Omeros Corp Recent Developments
12.14 Prothix
12.14.1 Prothix Company Information
12.14.2 Prothix Business Overview
12.14.3 Prothix Revenue in Ischemia Reperfusion Injury Business (2020-2025)
12.14.4 Prothix Ischemia Reperfusion Injury Product Portfolio
12.14.5 Prothix Recent Developments
12.15 SBI Pharmaceuticals
12.15.1 SBI Pharmaceuticals Company Information
12.15.2 SBI Pharmaceuticals Business Overview
12.15.3 SBI Pharmaceuticals Revenue in Ischemia Reperfusion Injury Business (2020-2025)
12.15.4 SBI Pharmaceuticals Ischemia Reperfusion Injury Product Portfolio
12.15.5 SBI Pharmaceuticals Recent Developments
13 Report Conclusion
14 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings